AFTON SWANSON: Open Payments
NPI 1639951031 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 34 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $139 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $97 |
| JAZZ PHARMACEUTICALS INC. | 3 | $85 |
| ABBVIE INC. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Lilly USA, LLC | 2 | $58 |
| Karyopharm Therapeutics Inc. | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
| SERVIER PHARMACEUTICALS LLC | 1 | $23 |
Products named: ZEPZELCA, ENHERTU, VERZENIO, KEYTRUDA, EPKINLY, XPOVIO, LYNPARZA, NINLARO.
Industry payments across IL — which companies pay providers there.
